×
Hero Background

Asia Pacific Glaucoma Treatment Companies

ID: MRFR/Pharma/2176-HCR
70 Pages
Rahul Gotadki
October 2025

Glaucoma is a group of eye conditions that can cause optic nerve damage and vision loss. The treatment landscape includes medications, surgical procedures, and medical devices aimed at managing intraocular pressure and preserving vision.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Asia-Pacific Glaucoma Treatment Market Research Report- Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Asia Pacific Glaucoma Treatment Market

Asia-Pacific Glaucoma Treatment Key Companies

 

Latest Asia-Pacific Glaucoma Treatment Companies Update


Santen Pharmaceutical Co., Ltd. announces regulatory approval for its Rhokinase inhibitor, Roclatan®, in mainland China, expanding its reach in the largest Glaucoma market in the Asia-Pacific region.


Senju Pharmaceutical Co., Ltd. receives marketing authorization for its prostaglandin analog Travatan® in Indonesia, offering another treatment option for patients in the region.Aeon Vis launches its glaucoma drainage implant, Aquaflow®, in South Korea, providing a minimally invasive alternative for managing severe glaucoma cases.


Glaukos Corporation partners with Alcon Laboratories to distribute its iStent® Inject Trabecular Micro-Bypass System in India and South Korea, leveraging Alcon's established distribution network to reach more patients.


Merck & Co., Inc. collaborates with Bausch + Lomb to develop and commercialize novel therapies for glaucoma in the Asia-Pacific region, combining their expertise and resources to accelerate drug development and market access.


List of Asia-Pacific Glaucoma Treatment Key Companies in the Market



  • Novartis AG

  • Pfizer Inc.

  • Allergan

  • Merck & Co.

  • Ocular Therapeutix Inc

  • pSivida Corp

  • Icon Bioscience Inc

  • Amorphex Therapeutics LLC.

  • Ellex

  • Quantel

  • Lumenis

  • and Lightmed